AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 116 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $61,752,000 | +57.0% | 1,631,500 | +56.5% | 0.01% | +37.5% |
| Q3 2016 | $39,343,000 | +130.0% | 1,042,480 | +7.3% | 0.01% | +100.0% |
| Q2 2016 | $17,105,000 | +59.9% | 971,896 | +10.5% | 0.00% | +100.0% |
| Q1 2016 | $10,698,000 | -49.0% | 879,783 | +2.1% | 0.00% | -60.0% |
| Q4 2015 | $20,992,000 | +30.6% | 862,079 | -4.9% | 0.01% | +25.0% |
| Q3 2015 | $16,075,000 | +4.7% | 906,167 | +4.2% | 0.00% | 0.0% |
| Q2 2015 | $15,349,000 | -18.1% | 869,649 | +45.4% | 0.00% | 0.0% |
| Q1 2015 | $18,750,000 | +12.0% | 598,292 | +4.3% | 0.00% | 0.0% |
| Q4 2014 | $16,745,000 | +224.9% | 573,672 | +130.3% | 0.00% | +300.0% |
| Q3 2014 | $5,154,000 | -18.5% | 249,098 | -2.4% | 0.00% | -50.0% |
| Q2 2014 | $6,324,000 | +35.0% | 255,321 | +15.5% | 0.00% | +100.0% |
| Q1 2014 | $4,686,000 | +26.6% | 221,123 | +7.3% | 0.00% | 0.0% |
| Q4 2013 | $3,701,000 | – | 206,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |